Poland· PL-100093688
Visipaque
A iodixanol product containing iodixanolum, registered in Poland by GE Healthcare AS. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Iodixanol is registered in 16 of 19 countries.
Countries holding a registration under ATC V08AB09 (iodixanol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Iodixanol · ATC V08AB09
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Iodixanolum
- Manufacturer
- GE Healthcare AS
- Country
- Poland (PL)
- ATC code
- V08AB09
- ATC class
- Iodixanol
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 14
- gtin05909990482412
- gtin05909990482436
- gtin05909990482443
- gtin05909990482450
- gtin05909990482474
- gtin05909990077236
- gtin05909990077281
- gtin05909990077298
- gtin05909990077304
- gtin05909990080069
- gtin05909990080076
- gtin05909990482481
- gtin05909990482467
- gtin05909990482429
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
172 interactions on record for iodixanol.
Graded by severity as the source publishes them — 87 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iodixanol · interactions on record
172 records
- 87 severe
- 50 moderate
- 35 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Amphotericin BA07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Iodixanol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVISIPAQUEGE Healthcare AS, Oslo
- United KingdomVisipaque 270 solution for injection 100ml bottlesGE Healthcare Ltd
- BelgiumVisipaque 270 mg I/mlGE Healthcare
- United StatesIodixanolFRESENIUS KABI USA, LLC
- GermanyVisipaqueGe Healthcare Buchler Gmbh & Co. Kg
- IrelandVISIPAQUE 270 mg I/ml Solution for Injection, glass containerGE Healthcare AS
- FinlandVisipaqueGE Healthcare AS
- CanadaVISIPAQUE 270GE HEALTHCARE CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Visipaque
- Belgium · Visipaque
- Bulgaria · Визипак
- Cyprus · Visipaque
- Czechia · Visipaque
- Germany · Visipaque
- Denmark · Visipaque
- Estonia · Visipaque
- Spain · Visipaque
- Finland · Visipaque
- France · Visipaque
- United Kingdom (Northern Ireland) · Visipaque
- Greece · Visipaque
- Croatia · Visipaque
- Hungary · Visipaque
- Ireland · Visipaque Glass Container, Visipaque Polypropylene Container
- Iceland · Visipaque
- Italy · Visipaque
- Lithuania · Visipaque
- Luxembourg · Visipaque
- Latvia · Visipaque
- Malta · Visipaque
- Netherlands · Visipaque
- Norway · Visipaque
- Portugal · Visipaque
- Romania · Visipaque
- Sweden · Visipaque
- Slovenia · Visipaque
- Slovakia · Visipaque
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f455d1be-e825-41a9-891a-386c613476b2 GET /v1/drugs/f455d1be-e825-41a9-891a-386c613476b2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "550 mg/ml (270 mg jodu/ml)",
"packaging": "05909990482412 ¦ Rp ¦ Skasowane ¦ 13668\n1 fiol. 20 ml\n05909990482436 ¦ Rp ¦ Skasowane ¦ 13669\n1 butelka 50 ml\n05909990482443 ¦ Rp ¦ 13672\n10 butelek 50 ml\n05909990482450 ¦ Rp ¦ Skasowane ¦ 13673\n1 butelka 100 ml\n05909990482474 ¦ Rp ¦ Skasowane ¦ 13674\n1 butelka 200 ml\n05909990077236 ¦ Rp ¦ Skasowane ¦ 38272\n1 butelka 50 ml\n05909990077281 ¦ Rp ¦ 38273\n10 butelek 50 ml\n05909990077298 ¦ Rp ¦ Skasowane ¦ 38274\n1 butelka 100 ml\n05909990077304 ¦ Rp ¦ 38275\n10 butelek 100 ml\n05909990080069 ¦ Rp ¦ Skasowane ¦ 38521\n1 fiol. 20 ml\n05909990080076 ¦ Rp ¦ Skasowane ¦ 38522\n10 fiol. 20 ml\n05909990482481 ¦ Rp ¦ 57277\n6 butelek 200 ml\n05909990482467 ¦ Rp ¦ 57278\n10 butelek 100 ml\n05909990482429 ¦ Rp ¦ 57279\n10 fiol. 20 ml",
"substance": "Iodixanolum 550 mg/ml",
"common_name": "Iodixanolum",
"pl_product_id": "100093688",
"pozwolenie_nr": "04824",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about iodixanol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.